Calcium hydroxylapatite tissue filler discovered 6 years after implantation into the nasolabial fold: Case report and review

Dermatologic Surgery

Volumn 35, Issue SUPPL. 1, 2009, Pages 375-379

  Shumaker, Peter R ^a   Lawrence Sakas, E ^a   Swann, Michael H ^a   Greenway Jr , Hubert T ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYAPATITE; MICROSPHERE; MUCIN;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CASE REPORT; CELL VACUOLE; CHEMOSURGERY; DERMIS; FACE; FEMALE; FIBROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMPLANTATION; INFLAMMATION; LYMPHOCYTOSIS; NASOLABIAL FOLD; PRIORITY JOURNAL; SKIN; STAINING;

BIOCOMPATIBLE MATERIALS; CARCINOMA, BASAL CELL; COSMETIC TECHNIQUES; DERMIS; DURAPATITE; FEMALE; FIBROSIS; FOREIGN-BODY REACTION; HUMANS; INJECTIONS, INTRADERMAL; MICROSPHERES; MIDDLE AGED; MOHS SURGERY; PROSTHESES AND IMPLANTS; SKIN NEOPLASMS; TIME FACTORS;

EID: 59349089561     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2008.01050.x     Document Type: Article

References (21)

1. Radiesse® injectable implant [product insert]. San Mateo, CA : Bioform Medical Inc 2006.
2. Flaharty P. Radiance. Fac Plast Surg 2004 20 : 165 9.
3. Laeschke K. Biocompatability of microparticles into soft tissue fillers. Semin Cutan Med Surg 2004 23 : 214 7.
4. Misiek DJ, Kent JN, Carr RF. Soft tissue responses to hydroxylapatite particles of different shapes. J Oral Maxillofac Surg 1984 42 : 150 60.
5. Morhenn VB, Lemperle G, Gallo RL. Phagocytosis of different particulate dermal filler substances by human macrophages and skin cells. Dermatol Surg 2002 28 : 484 90.
6. Nicolau PJ. Long-lasting and permanent fillers: biomaterial influence over host tissue response. Plast Reconstruct Surg 2007 119 : 2271 86.
7. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesth Plast Surg 2003 27 : 354 66.
8. Lemperle G, Morhenn V, Pestonjamasp V, et al. Migration studies and histology of injectable microspheres of different sizes in mice. Plast Reconstruct Surg 2004 113 : 1380 90.
9. Drobeck HP, Rothstein SS, Gumaer KI, et al. Histologic observation of soft tissue responses to implanted, multifaceted particles and disks of hydroxylapatite. J Oral Maxillofac Surg 1984 42 : 143 9.
10. Marmur ES, Phelps R, Goldberg DJ. Clinical, histological, and electron microscopic findings after injection of calcium hydroxyapatite filler. J Cosmet Laser Ther 2004 6 : 223 6.
11. Jansen DA, Graivier MH. Evaluation of calcium hydroxyapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg 2006 118 (3 Suppl) : 22S 30S.
12. Sankar V, McGuff HS. Foreign body reaction to calcium hydroxyapatite after lip augmentation. J Am Dent Assoc 2007 138 : 1093 6.
13. Iezzi G, Scarano A, Petrone G, et al. Two human hydroxyapatite-coated dental implants retrieved after a 14-year loading period: a histologic and histomorphometric case report. J Periodontal 2007 78 : 940 7.
14. Proussaefs P, Lozada J, Valencia G, et al. Histologic evaluation of a hydroxyapatite onlay bone graft retrieved after 9 years: a clinical report. J Prosthet Dent 2002 87 : 481 4.
15. Jarcho M. Biomaterial aspects of calcium phosphates. Properties and applications. Dent Clin N Am 1986 30 : 25 47.
16. Frame JW. Hydroxyapatite as a biomaterial for alveolar ridge augmentation. Int J Oral Maxillofac Surg 1987 16 : 642 55.
17. Alam M, Yoo SS. Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions. J Am Acad Dermatol 2007 56 : 285 9.
18. Moers-Carpi M, Vogt S, Santos BM, et al. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg 2007 33 : S144 51.
19. Moers-Carpi MM, Tufet JO. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial. Dermatol Surg 2008 34 : 210 5.
20. Silvers SL, Eviatar JA, Echavez MI, et al. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability. Plast Reconstr Surg 2006 118 (3 Suppl) : 34S 45S.
21. Bennett R, Taher M. Restylane persistent for 23 months found during Mohs micrographic surgery: a source of confusion with hyaluronic acid surrounding basal cell carcinoma. Dermatol Surg 2005 31 : 1366 9.